Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2020 Sep 26;147(1):167–175. doi: 10.1007/s00432-020-03395-4

Table 1.

Clinical and pathological characteristics of Egyptian HCC patients.

Variable N (%) Total=47
Age Mean±SD 57.02±6.92
Sex Male 37 (21.3)
Female 10 (78.7)
Etiology HCV 42 (89.4)
HBV 2 (4.3)
Mixed 1 (2.1)
Negative 2 (4.3)
Site Left 24 (51.06)
Right 22 (46.82)
Unknown 1 (2.12)
Grade II 24 (51.06)
III 23 (48.9)
Margin Free 34 (72.3)
Involved 13 (27.7)
Focality Solitary 34 (72.3)
Multiple 13 (27.7)
Type Solid 21 (44.7)
Trabecular, Acinar 25 (53.2)
Trabecular, Solid 1 (2.1)
Adjacent liver Cirrhotic 36 (76.6)
Non-Cirrhotic 10 (21.27)
Unknown 1 (2.13)
Vascular Invasion Yes 24 (51.1)
No 23 (48.9)
Pathological staging T1 13 (27.7)
T2 30 (63.8)
T3a 3 (6.4)
T4 1 (2.1)
Survival Alive 34 (72.34)
Dead 13 (27.66)
Recurrence Yes 10 (21.28)
No 37 (78.72)